Updates ·
Health notices · Thursday 20 August
3 notices from the agencies today, in plain words, each with the original linked.
Prince Bakery recalls breads due to undeclared milk or sesame
Centers for Disease Control and Prevention (CDC) · Food safety
If you have an allergy or severe sensitivity to milk or sesame, this may affect you. CDC says Prince Bakery Inc is recalling multiple Prince brand breads.
The recall is for Prince brand Sesame Italian Bread, Large Italian Bread, Large Sesame French Bread, Long Sesame French Bread, and Pan de Manteca Spanish Style Bread.
These products may contain undeclared sesame or milk, which can be risky for people with these allergies.
What to do
- Check whether you have the recalled Prince Bakery breads listed in the alert, and do not eat them.
Class II inspection recall for mirabegron extended-release tablets
FDA · Recall
If you take mirabegron extended-release tablets for bladder symptoms, the Food and Drug Administration (FDA) says there is a Class II problem with certain bottles.
The issue is linked to an out-of-specification (OOS) test result for an impurity called N-nitroso mirabegron.
The FDA notice was published 2026-08-12 and says the product was distributed nationwide in the USA.
FDA approves TREGZI for Treg cell immunotherapy in blood cancer transplants
FDA · Announcement
If you are an adult with a blood cancer who is having an allogeneic hematopoietic stem cell transplantation, the FDA has approved TREGZI, a regulatory T (Treg) cell-based immunotherapy.
Allogeneic transplantation uses donor stem cells. Graft-versus-host disease (GVHD) is when donor immune cells attack your body; the approval is for chronic GVHD-free survival.
The approval was announced on 2026-06-30. If you are being considered for this transplant, ask your transplant team whether TREGZI is part of your treatment plan.
Where this comes from
- Prince Bakery recalls breads due to undeclared milk or sesameCDC — food safety
- Class II inspection recall for mirabegron extended-release tabletsUS Food and Drug Administration — enforcement report
- FDA approves TREGZI for Treg cell immunotherapy in blood cancer transplantsfda-press
Each notice above is summarised from the agency's own publication, linked beside it. Nothing here is a finding of ours.